Has John Bullinga, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,708 in general payments to John Bullinga, MD across 173 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Bullinga, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Bullinga, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Bullinga, MD

Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1699706994

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 59.5% of the total. Reporting peaked in 2023 at $7,327 and has fallen 72.5% since, to $2,017 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in PA, where the typical reported total is $15,643.

$14,708in general payments, 2019–2025

Across 173 payments — averaging $85.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$9K
Abbott$3K
Boston Scientific$2K
Biosense Webster, Inc.$1K
Biotronik Inc.$320
Cardiva Medical, Inc.$45
plus $118 from 6 others

$79,596in research payments, 2019–2025

Across 28 payments — averaging $2842.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$70K
Boehringer Ingelheim$10K

What the payments were for

Speaking & faculty fees$4,90033%
Travel & lodging$4,16128%
Food & beverage$5,64738%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	45	$8,752
Abbott	64	$2,643
Boston Scientific	22	$1,759
Biosense Webster, Inc.	29	$1,071
Biotronik Inc.	4	$320
Cardiva Medical, Inc.	2	$45
Biosig Technologies, Inc.	1	$35
E.r. Squibb & Sons, L.L.C.	2	$26
Abiomed	1	$21
Boehringer Ingelheim	1	$13
Philips North America LLC	1	$12
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,708 in reported general payments places this provider in the 45th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$280,287

Medicare patients

951

Services billed

2,755

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	166	$189,958
XareltoRivaroxaban	27	$36,199
EntrestoSacubitril/Valsartan	11	$21,983
Flecainide Acetate	157	$7,746
Dofetilide	23	$6,511
Metoprolol Succinate	160	$2,625
Amiodarone Hcl	58	$2,584
Carvedilol	80	$1,029
SotalolSotalol Hcl	26	$681
Digoxin	14	$382
Metoprolol Tartrate	49	$224
Amlodipine Besylate	27	$217
Spironolactone	25	$154
Furosemide	25	$145
Atenolol	14	$141

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Philadelphia

Fermin GarciaPhiladelphia$684K
Ralph VerdinoPhiladelphia$682K
Pasquale SantangeliPhiladelphia$581K
Francis MarchlinskiPhiladelphia$469K
Joshua CooperPhiladelphia$405K
Timothy MarkmanPhiladelphia$402K
David CallansPhiladelphia$350K
Robert SchallerPhiladelphia$333K
Matthew HymanPhiladelphia$294K
David FrankelPhiladelphia$218K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →